Tamoxifen drug loading solid lipid nanoparticles prepared by hot high pressure homogenization techniques

American Journal of Pharmacology and Toxicology

Volumn 3, Issue 3, 2008, Pages 219-224

  Al Haj, Nagi A ^a   Abdullah, Rasedee ^a   Ibrahim, Siddig ^b   Bustamam, Ahmad ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b NONE

Author keywords

Breast cancer; Cytotoxicity; Drug loading; High pressure homogenizatition; Solid lipid nanoparticles; Tamoxifen

Indexed keywords

ANTIESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; SOLID LIPID NANOPARTICLE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN MCF 7; CYTOTOXICITY TEST; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE PROCEDURES; HOT HIGH PRESSURE HOMOGENIZATION TECHNIQUE; HUMAN; HUMAN CELL; IN VITRO STUDY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 65549120303     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2008.219.224     Document Type: Article

References (19)

1. Miglietta, A., R. Cavalli, C. Bocca, L. Gabriel and M.R. Gasco, 2000. Cellular uptake and cytotoxicity of Solid Lipid Nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int. J. Pharm., 210: 61-67. DOI: 10.1016/S0378-5173(00)00562-7
2. zur Mühlen, A., C. Schwarz and W. Mehnert, 1998. Solid Lipid Nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism. Eur. J. Pharm. Biopharm., 45: 149-155. DOI: 10.1016/ S0939-6411(97)00150-1
3. AL-Haj, N. and A. Rasedee, 2008. Solid lipid nanoparticles preparation and characterization. Int. J. Pharmacol., 4: 1-4.
4. Sjostrom, B. and B. Bergenstahl, 1992. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm., 88: 53-62. http://cat.inist.fr/?aModele=afficheN&cpsidt=4445275
5. Freitas, C. and R.H. Müller, 1999. Correlation between long-term stability of Solid Lipid Nanoparticles (SLN) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm., 47: 125-132. DOI: 10.1016/ S0939-6411(98)00074-5
6. Hu, F.Q., S.P. Jiang, Y.Z. Du and H. Yuan et al., 2005. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B: Biointerface., 45: 167-173. DOI: 10.1016/j.colsurfb.2005.08.005
7. Hu, F.Q., S.P. Jiang, Y.Z. Du, H. Yuan, Y.Q. Ye and S. Zeng, 2006. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm., 314: 83-89. DOI: 10.1016/J.IJPHARM.2006.01.040
8. Lander, R., W. Manger, M. Scouloudis, A. Ku, O. Davis and A. Lee, 2000. Gaulin homogenization: A mechanistic study. Biotechnol. Prog., 16: 80-85. http://cat.inist.fr/?aModele=afficheN&cpsidt=1281126
9. Lippacher, A., R.H. Muller and K. Mader, 2002. Semisolid SLN™ dispersions for topical application: Influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm., 53: 155-160. http://cat.inist.fr/?aModele= afficheN&cpsidt=13554837
10. Lippacher, R.H. Muller and K. Mader, 2004. Liquid and semisolid SLN™ dispersions for topical application: Rheological characterization. Eur. J. Pharm. Biopharm., 58: 561-567. DOI: 10.1016/ j.ejpb.2004.04.009
11. MacGregor, J.I. and V.C. Jordan, 1998. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 50: 151-196. http://pharmrev.aspetjournals.org/cgi/content/abstract/50/2/151
12. Mehnert, W. and K. Mader, 2001. Solid lipid nanoparticles production, characterization and applications. Adv. Drug Deliv. Rev., 47: 165-196. DOI: 10.1016/S0169-409X(01)00105-3
13. Muller, H., K. Mader and S. Gohla, 2000. Solid Lipid Nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm., 50: 161-177. DOI: 10.1016/S0939-6411(00)00087-4
14. Siekmann, B. and K. Westesen, 1994. Melt-homogenized solid lipid nanoparticles stabilized by the nontonic surfactant tyloxapol 1. Preparation and particle size determination. Pharm. Pharmacol. Lett., 3: 194-197. DOI: 10.1016/S0142-9612(02)00578-1
15. Ugazio, E., R. Cavalli and M.R. Gasco, 2002. Incorporation of cyclosporin A in Solid Lipid Nanoparticles (SLN). Int. J. Pharm., 241: 341-344. DOI: 10.1016/S0378-5173(02)00268-5
16. Wan, F., J. You, Y. Sun, Z. Xing-Guo and C. Fu-De, 2008. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): Preparation and evaluation in vitro, I. Int. J. Pharm., 359: 104-110. DOI: 10.1016/j.ijpharm.2008.03.030
17. Westesen, K., H. Bunjes and M.H.J. Koch, 1997. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control Release, 48: 223-236. DOI: 10.1016/S0168-3659(97)00046-1
18. Wissing, S.A. and R.H. Müller, 2002. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J. Control Release, 81: 225-233. DOI: 10.1016/ S0168-3659(02)00056-1
19. Liedtke, S., S. Wissing, R.H. Müller and K. Mäder, 2000. Influence of high pressure homogenisation equipment on nanodispersions characteristics. Int. J. Pharm., 196: 183-185. DOI: 10.1016/ S0378-5173(99)00417-2